LYKALABS.NS
Lyka Labs Limited
NSEINREQUITY
Healthcare
DELAYED
Last price
73.62
▲ 1.44 (2.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
73.62
Prev close
72.18
Day high
73.62
Day low
73.62
Volume
7.62K
Market cap
$2.66B
P/E (TTM)
—
52W range
44.10 – 102.55
Day trading desk
Gap from prior close
+2.00%
Prior close 72.18
VWAP
73.62
0.00% from price
Relative volume
0.12×
Quiet session
Session range
—
73.62 – 73.62
Position in range
—
—
ATR (14D)
1.83
2.48% of price
Prior day high
72.18
PDH
Prior day low
72.18
PDL
Bid / ask spread
—
Quote not published
Session volume
5.20K
Avg 43.66K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+10.37%
+11.7%
1M
+17.06%
+13.3%
3M
+23.05%
+20.0%
6M
+9.47%
-1.6%
YTD
-2.99%
-15.3%
1Y
-26.02%
-46.0%
3Y
-34.47%
-108.6%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on LYKALABS.NS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
21.38M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 29, 26 | Gandhi (Kunal Narendra) Promoter |
— | 14.18K | — | Direct |
| Jun 25, 26 | Enai Trading & Investment Pvt Ltd Promoter |
— | 11.31K | — | Direct |
| Jun 25, 26 | Gandhi (Alisha Kunal) Promoter |
— | 5.00K | — | Direct |
| Jun 25, 26 | Gandhi (Kunal Narendra) Promoter |
— | 6.53K | — | Direct |
| Jun 25, 26 | Gandhi (Nehal Narendra) Promoter |
— | 33.12K | — | Direct |
| Jun 25, 25 | Gandhi (Nehal Narendra) Promoter |
— | 99.00K | — | Direct |
| Mar 24, 25 | Gandhi (Kunal Narendra) Promoter |
— | 1.07M | — | Direct |
| Mar 24, 25 | Gandhi (Nehal Narendra) Promoter |
— | 1.07M | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Enai Trading & Investment Pvt Ltd |
Promoter | 1.01M | Acquisition |
Gandhi (Alisha Kunal) |
Promoter | 50.00K | Acquisition |
Gandhi (Kunal Narendra) |
Promoter | 3.51M | Acquisition |
Gandhi (Nehal Narendra) |
Promoter | 1.20M | Acquisition |
Fundamentals
Market cap$2.66B
Enterprise value—
Revenue (TTM)$1.30B
Gross profit$761.38M
EBITDA$-26.54M
Net income$-7.62M
EPS (TTM)$-2.49
Free cash flow—
Total cash—
Total debt—
Book value / share$25.89
Shares outstanding36.15M
Float14.29M
Short % of float—
Dividend yield—
Beta (5Y)0.35
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book2.84
EV / revenue—
EV / EBITDA—
Gross margin58.46%
Operating margin-0.68%
Profit margin-0.50%
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $1.28B | $1.38B | $1.05B | $883.39M | — | -7.3% |
| Operating revenue | $1.28B | $1.38B | $1.05B | $883.39M | — | -7.3% |
| Cost of revenue | $501.99M | $555.92M | $451.92M | $378.68M | — | -9.7% |
| Gross profit | $782.46M | $829.04M | $599.41M | $504.71M | — | -5.6% |
| Research & development | — | $9.79M | $6.38M | — | — | — |
| Selling, general & admin | — | $78.64M | $57.82M | $51.58M | $59.68M | — |
| Total operating expense | $903.63M | $717.38M | $569.81M | $477.24M | — | +26.0% |
| Operating income | -$121.17M | $111.66M | $29.59M | $27.47M | — | -208.5% |
| Net interest income | -$31.60M | -$22.73M | -$39.47M | -$97.16M | — | -39.1% |
| Pre-tax income | -$117.79M | $111.25M | -$9.34M | -$131.71M | — | -205.9% |
| Tax provision | -$13.44M | $31.92M | $16.87M | -$187.00K | — | -142.1% |
| Net income | -$100.32M | $80.12M | -$24.89M | -$132.12M | — | -225.2% |
| Net income to common | -$100.32M | $80.12M | -$24.89M | -$132.12M | — | -225.2% |
| Basic EPS | -2.81 | 2.22 | -0.75 | -4.63 | — | -226.6% |
| Diluted EPS | -2.81 | 2.22 | -0.75 | -4.63 | — | -226.6% |
| EBIT | -$86.19M | $133.97M | $37.56M | -$14.47M | — | -164.3% |
| EBITDA | -$1.59M | $201.67M | $165.57M | $127.00M | — | -100.8% |
| Basic shares | 35.70M | 36.09M | 32.98M | 28.78M | — | -1.1% |
| Diluted shares | 35.70M | 36.09M | 32.98M | 28.78M | — | -1.1% |
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $13.59M | $3.89M | $2.57M | $27.42M | — | +249.1% |
| Cash & short-term investments | $69.17M | $50.46M | $33.60M | $140.28M | — | +37.1% |
| Accounts receivable | $350.35M | $430.77M | $269.93M | $201.26M | — | -18.7% |
| Inventory | $136.30M | $124.66M | $95.72M | $69.54M | — | +9.3% |
| Total current assets | $632.78M | $674.32M | $506.52M | $442.04M | — | -6.2% |
| Property, plant & equipment | $822.57M | $772.88M | $711.22M | $637.57M | — | +6.4% |
| Goodwill & intangibles | $67.33M | $92.19M | $119.10M | $206.53M | — | -27.0% |
| Total assets | $1.75B | $1.76B | $1.57B | $1.52B | — | -0.9% |
| Total current liabilities | $538.99M | $466.31M | $377.71M | $325.98M | — | +15.6% |
| Current debt | $253.67M | $187.89M | $137.93M | $77.69M | — | +35.0% |
| Long-term debt | $229.89M | $181.22M | $418.26M | $623.25M | — | +26.9% |
| Total debt | $488.69M | $381.70M | $576.99M | $736.82M | — | +28.0% |
| Total liabilities | $837.05M | $726.24M | $885.90M | $1.06B | — | +15.3% |
| Retained earnings | — | -$1.30B | -$1.38B | -$1.36B | -$1.22B | — |
| Shareholder equity | $923.93M | $1.04B | $681.54M | $454.41M | — | -10.8% |
| Working capital | $93.79M | $208.00M | $128.81M | $116.06M | — | -54.9% |
| Net tangible assets | $856.61M | $943.31M | $562.45M | $247.87M | — | -9.2% |
| Shares issued | 35.69M | 35.69M | 33.09M | 30.69M | — | 0.0% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | -$117.79M | $111.25M | -$9.34M | -$131.71M | -205.9% |
| Depreciation & amortisation | $84.60M | $67.69M | $128.02M | $141.47M | +25.0% |
| Change in working capital | -$25.00M | -$146.51M | -$137.99M | -$98.59M | +82.9% |
| Operating cash flow | $52.43M | $18.99M | $17.73M | $89.53M | +176.0% |
| Capital expenditure | -$111.31M | -$156.55M | -$92.31M | -$81.85M | +28.9% |
| Investing cash flow | -$94.14M | -$117.96M | -$94.88M | $73.50M | +20.2% |
| Financing cash flow | $41.86M | $52.92M | $19.53M | -$216.43M | -20.9% |
| Free cash flow | -$58.88M | -$137.55M | -$74.58M | $7.67M | +57.2% |
| End cash position | $13.59M | $13.44M | $59.49M | $117.11M | +1.1% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $280.31M | $307.28M | $366.61M | $330.25M | $334.29M | -8.8% |
| Operating revenue | $280.31M | $307.28M | $366.61M | $330.25M | $334.29M | -8.8% |
| Cost of revenue | $110.30M | $115.53M | $148.78M | $127.38M | $130.85M | -4.5% |
| Gross profit | $170.01M | $191.75M | $217.83M | $202.87M | $203.44M | -11.3% |
| Total operating expense | $254.97M | $196.81M | $264.73M | $187.13M | $176.78M | +29.6% |
| Operating income | -$84.96M | -$5.06M | -$46.90M | $15.75M | $26.66M | -1,579.4% |
| Net interest income | -$7.01M | -$8.16M | -$7.89M | -$8.54M | -$4.68M | +14.1% |
| Pre-tax income | -$85.86M | -$1.60M | -$43.85M | $13.52M | $30.18M | -5,263.0% |
| Tax provision | -$5.20M | -$89.00K | -$11.71M | $3.56M | $9.89M | -5,741.6% |
| Net income | -$76.07M | -$3.00K | -$33.57M | $9.33M | $17.71M | -2,535,500.0% |
| Net income to common | -$76.07M | -$3.00K | -$33.57M | $9.33M | $17.71M | -2,535,500.0% |
| Basic EPS | -2.13 | 0.00 | -0.94 | 0.25 | 0.49 | — |
| Diluted EPS | -2.13 | 0.00 | -0.94 | 0.25 | 0.49 | — |
| EBIT | -$78.85M | $6.56M | -$35.96M | $22.05M | $34.86M | -1,301.4% |
| EBITDA | -$58.41M | $28.11M | -$14.47M | $43.17M | $49.03M | -307.8% |
| Basic shares | 35.71M | 35.69M | 35.72M | 37.30M | 36.15M | +0.1% |
| Diluted shares | 35.71M | 35.69M | 35.72M | 37.30M | 36.15M | +0.1% |
| Line item | 2026-03-31 | 2025-09-30 | 2025-03-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $13.59M | $11.64M | $3.89M | +16.7% |
| Cash & short-term investments | $69.17M | $65.95M | $50.46M | +4.9% |
| Accounts receivable | $350.35M | $370.64M | $430.77M | -5.5% |
| Inventory | $136.30M | $115.37M | $124.66M | +18.1% |
| Total current assets | $632.78M | $606.16M | $674.32M | +4.4% |
| Property, plant & equipment | $822.57M | $792.13M | $772.88M | +3.8% |
| Goodwill & intangibles | $67.33M | $80.66M | $92.19M | -16.5% |
| Total assets | $1.75B | $1.68B | $1.76B | +4.0% |
| Total current liabilities | $538.99M | $429.80M | $466.31M | +25.4% |
| Current debt | $253.67M | $125.12M | $187.89M | +102.7% |
| Long-term debt | $229.89M | $182.69M | $181.22M | +25.8% |
| Total debt | $488.69M | $316.57M | $381.70M | +54.4% |
| Total liabilities | $837.05M | $664.32M | $726.24M | +26.0% |
| Retained earnings | — | — | -$1.30B | — |
| Shareholder equity | $923.93M | $1.01B | $1.04B | -8.6% |
| Working capital | $93.79M | $176.37M | $208.00M | -46.8% |
| Net tangible assets | $856.61M | $930.60M | $943.31M | -8.0% |
| Shares issued | 35.69M | 35.69M | 35.69M | 0.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders59.94%
Held by institutions0.00%
Institutions holding0
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
69.16
+6.45% from price
SMA 20
66.63
+10.49% from price
SMA 50
68.35
+7.71% from price
SMA 100
64.28
+14.53% from price
SMA 200
68.49
+7.48% from price
EMA 12
69.26
+6.30% from price
EMA 26
67.98
+8.30% from price
EMA 50
67.10
+9.71% from price
RSI (14)
64.7
Neutral
MACD (12,26,9)
1.28
Hist 0.85
ATR (14)
1.83
2.48% of price
Realised vol 30D
41.1%
Annualised
Bollinger upper
74.40
20, 2σ
Bollinger lower
58.85
20, 2σ
50 / 200 cross
Death
68.35 vs 68.49
Trend bias
Above 200
+7.48%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.47
Less volatile than market
Correlation to SPY
0.14
Largely independent
Realised vol 30D
41.1%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-55.5%
Peak to trough
Max drawdown 5Y
-82.3%
Peak to trough
ATR 14
1.83
2.48% of price
Beta (reported)
0.35
5Y monthly, from filing
Headlines
Nervous About the Stock Market? History Has Encouraging News for Long-Term Investors.
Motley Fool · 6m ago
Johnson & Johnson (JNJ) Wins EU Approval For TECVAYLI Combo In Multiple Myeloma
Simply Wall St. · 13m ago
Will Alaska Air (ALK)ʼs New Seattle–Europe Routes Redefine Its International Growth Narrative?
Simply Wall St. · 13m ago
Traeger (COOK) Stock Fair Value Rises After Q2 Margin Strength Lifts Analyst Targets
Simply Wall St. · 13m ago
Cigna Group (CI) Could Be 19% Undervalued As AI Spotlight Meets Growth Narrative
Simply Wall St. · 13m ago
Is Excelerate Energy (EE) Still Below Fair Value Following Its Recent Rally?
Simply Wall St. · 13m ago
Kane voted German footballer of the year
AFP · 15m ago
Asphalt Expert Robert Stewart Explains Asphalt Driveway Installation Preparation in HelloNation
PR Newswire · 17m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.